The largest database of trusted experimental protocols

353 protocols using incucyte s3

1

Cellular Growth Monitoring with Incucyte

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were plated on 96 well plates (Corning Cat. no. 353072) in 200 μL of DMEM supplemented with FBS. Plates were then inserted into the Essen Bioscience Incucyte S3 imaging system with plates imaged every 6 h. After 48 h of growth, cells were treated with inhibitors and pH 7.4/6.5, and imaging continued every 6 h. After seven days from initial plating, Incucyte images were analyzed for confluence using the provided Incucyte S3 software. The confluency was plotted against time, and p value was calculated using the GraphPad Prizm 8.1.1 program. The outer two rows as well as the outer two columns were disregarded from analysis due to edge-related evaporation effects of the plates.
+ Open protocol
+ Expand
2

Quantifying mCherry Expression in LNP-treated H358 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
NCI-H358 cells were seeded and grown for 24 h in 384-well plates and then dosed with LNP by Echo acoustic dispenser and an additional 20 μL of complete media was added (giving a total of 50 μL per well). The mCherry expression and phase contrast images were acquired using an Incucyte S3 (Essen Bioscience) widefield microscope with 10× objective every 4 h for a total of 48 h. Image analysis was performed using the integrated Incucyte S3 2019A software: fluorescence threshold level was adjusted to a value above the background level (nontransfected cells) in order to identify mCherry-expressing cells. mCherry total integrated intensity and mean cell confluence were determined using segmentation masks applied over the fluorescence and phase contrast images, respectively.
+ Open protocol
+ Expand
3

Opioid Effects on Vascular Smooth Muscle

Check if the same lab product or an alternative is used in the 5 most similar protocols
Aortic vascular smooth muscle cells were isolated from male and female rats with a Sprague Dawley background (11-13-week-old). Primary cells were then cultured in DMEM (Dulbecco's Modified Eagle Medium) with 10% FBS (Fetal Bovine Serum) and 1% P/S (penicillin-streptomycin). The medium was changed every 48 hours until the cells were ready to be passaged. Cells were cultured up to passage 2, and subsequently they were plated with 2500 cells/well. Treatment consisted of fresh medium containing either morphine (10 nM or 30 μM), hydrocodone (10 nM or 30 μM), or 0.1% DMSO control. The medium was not replaced until the end of the treatment. The plates were allocated to the IncuCyte S3 from Essenbioscience and real time images from cell were captured in a time-dependent manner (every 16 hours and up to 120 hours or 5 days). Images were analyzed for percent confluence over time with the IncuCyte S3 from Essenbioscience.
+ Open protocol
+ Expand
4

Cellular Growth Monitoring with Incucyte

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were plated on 96 well plates (Corning Cat. no. 353072) in 200 μL of DMEM supplemented with FBS. Plates were then inserted into the Essen Bioscience Incucyte S3 imaging system with plates imaged every 6 h. After 48 h of growth, cells were treated with inhibitors and pH 7.4/6.5, and imaging continued every 6 h. After seven days from initial plating, Incucyte images were analyzed for confluence using the provided Incucyte S3 software. The confluency was plotted against time, and p value was calculated using the GraphPad Prizm 8.1.1 program. The outer two rows as well as the outer two columns were disregarded from analysis due to edge-related evaporation effects of the plates.
+ Open protocol
+ Expand
5

IncuCyte S3 Quantification of GFP

Check if the same lab product or an alternative is used in the 5 most similar protocols
To quantify GFP expression, cells were plated in clear flat-bottomed 96-well plates (Nunc) and imaged every hour using the IncuCyte S3 live cell imaging system (Essen BioScience). Five fields of view were taken per well at 10× magnification, and GFP expression was determined using the total integrated intensity metric included in the IncuCyte S3 software (Essen BioScience). To analyse images generated on the IncyCyte S3, a collection of representative images is first taken to set fluorescence and cellular thresholds, which allows for the removal of background fluorescence, and selection of cell boundaries (‘objects’) by creating ‘masks’. Following this, the total integrated intensity metric can be accurately calculated by the software, which takes the total sum of objects’ fluorescent intensity in the image, expressed as green count units (GCU) µm−2.
+ Open protocol
+ Expand
6

Wound Healing Dynamics of HGSOC Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Wound healing of the HGSOC cells was measured for 72 h at 2-h intervals with an IncuCyte S3 high-content imager (Essen Bioscience, Ann Arbor, MI). Experiments were performed on 96-well plates (ImageLock, Essen BioScience) with adavosertib (500 nM) or vehicle (DMSO). Each sample was measured in triplicate, and the experiments were repeated a minimum of three times. Relative wound density was analyzed by IncuCyte software (Essen BioScience). The wells were precoated with Geltrex (Gibco) for migration experiments and with Matrigel (100 µg/ml, Corning, Bedford, MA, USA) for invasion experiments. Wells were pretreated for 24 h with adavosertib (500 nM) before wound making with a wound-maker provided with IncuCyte S3 (Essen Bioscience). In the invasion experiments after wound making, the cells were covered with 50 µl Matrigel (2 mg/ml) for 30 min in the incubator; thereafter, adavosertib was added.
+ Open protocol
+ Expand
7

mDA/BFCN Differentiation Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
mDA/BFCN differentiation assays were carried out as described above. Briefly, 2.5 × 105 indicated cell lines were cultured in differentiation medium for 4 days and then placed in Incucyte S3 (Sartorius, Germany), a simple, reliable, and easy method through the Incucyte S3 live-cell analysis system for cell viability assay,67 (link),68 ,69 for over time image acquisition. The plate was scanned from nine separate regions per well using a 20× objective lens every 24 h for 21 days. The images were then analyzed using the built-in tools, and the viable cell number (object count) changes over time, normalized to the indicated day, were plotted using the built-in software.
+ Open protocol
+ Expand
8

Comprehensive Cell Cycle Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
For cell cycle analyses, cells were harvested with trypsin (72 h post-transfection or otherwise indicated), fixed overnight in 70% ethanol at −20°C. DNA was stained with propidium iodide (Miltenyi Biotec; diluted 1:1000) at 37°C for 30 min in PBS supplemented with RNAse A (2 μg/ml; Sigma Aldrich) to deplete RNA. The DNA content was measured by flow cytometry using a MACS Quant Analyzer (Miltenyi Biotec) and analyzed using FlowJo. The FUCCI system was used to analyze the length of cell cycle phases. ES-2 cells, stably transduced with IncuCyte® Cell Cycle Red/Green Lentivirus Reagent (Sartorius), were transfected with indicated siRNAs. Cells in the G2/M phase were enriched by FACS based on their green fluorescence using a FACS Melody sorter (BD Bioscience) 24 h post-transfection. Cell cycles phases were monitored based on their fluorescence using an IncuCyte S3 (Sartorius) starting immediately after sorting. Cell segmentation and quantification was performed using the Cell-By-Cell module (IncuCyte S3; Sartorius). Single cell tracking was subsequently processed using ImageJ.
+ Open protocol
+ Expand
9

Antiproliferative Effects of Doxorubicin and Paclitaxel

Check if the same lab product or an alternative is used in the 5 most similar protocols
MDA-MB-468 and BT20 shCont, shCK5-22, and shCK17-73 cells were plated at 5000 cells/well in sexplicate in 96 well plates. Doxorubicin-HCl (15007) or Paclitaxel (10461, Cayman Chemical, Ann Arbor, MI, USA) were serially diluted and added at the indicated concentrations the following day. Wells were imaged using the IncuCyte S3 (Sartorius) using the 10X objective every 4 hours for 96 hours. Two images were acquired per well. Percent confluency was measured using IncuCyte S3 (Sartorius). GraphPad Prism 9 (GraphPad, San Diego, CA, US) was used to determine IC50 after 72 h treatment by plotting drug concentration vs. fold change, Log10 transforming concentration, normalizing, and performing nonlinear regression. Experiment was independently performed 3–4 times and 95% confidence intervals were calculated with GraphPad Prism 9 to determine statistical significance.
+ Open protocol
+ Expand
10

Quantifying PD-L1 and PD-1 Binding Kinetics

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antibody binding and blockade assays were performed as described previously (41 (link)). Briefly, to measure PD-L1 protein and PD-L1 antibody interaction, we seeded 1 × 104 BT549cPD-L1 cells per well in 96-well plates and then incubated the plates with cIgG control (Rockland Immunochemicals), or 12C10E4 antibody, and anti-canine Alexa Fluor 488 dye conjugate (SouthernBiotech). Every hour, green fluorescent signal was measured and quantified by IncuCyte S3 (Sartorius). To measure PD-1 protein on the cells, we seeded 1 × 104 BT549cPD-L1 cells per well in 96-well plates, and then incubated the plates with cIgG control (Rockland Immunochemicals), or 12C10E4 antibody, cPD-1-hFc protein (human Fc protein conjugated; SinoBiological US), and/or anti-human Alexa Fluor 488 dye conjugate (Thermo Fisher Scientific). Every 3 hours, green fluorescent signal was measured and quantified by IncuCyte S3 (Sartorius). The Image analysis was performed according to the manufacturer's protocol.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!